Abstract
Hydrogen sulfide (H2S), as an important endogenous signaling molecule, plays a vital role in many physiological processes. The abnormal behaviors of hydrogen sulfide in organisms may lead to various pathophysiological processes. Monitoring the changes in hydrogen sulfide is helpful for pre-warning and treating these pathophysiological processes. Fluorescence imaging techniques can be used to observe changes in the concentration of analytes in organisms in real-time. Therefore, employing fluorescent probes imaging to investigate the behaviors of hydrogen sulfide in pathophysiological processes is vital. This paper reviews the design strategy and sensing mechanisms of hydrogen sulfide-based fluorescent probes, focusing on imaging applications in various pathophysiological processes, including neurodegenerative diseases, inflammation, apoptosis, oxidative stress, organ injury, and diabetes. This review not only demonstrates the specific value of hydrogen sulfide fluorescent probes in preclinical studies but also illuminates the potential application in clinical diagnostics.
1 Introduction
Hydrogen sulfide (H2S) is the third gaseous signaling molecule found after carbon monoxide (CO) and nitric oxide (NO) (Szabo et al., 2013). Unlike other signaling molecules, H2S can freely penetrate the cell membrane without affecting the cell’s signaling response (Predmore et al., 2012). H2S is present both inside and outside the cell and is widely recognized in regulating nervous systems, cellular bioenergetics and metabolism, gene transcription and translation, vascular tone, and immune function (Cirino et al., 2022). Endogenous H2S is principally produced by three kinds of biological enzymes, including cystathionine γ-lyase (CSE), cystathionine β-synthase (CBS), and 3-mercaptopyruvate sulfurtransferase (3-MST) (Szabo et al., 2013; Augsburger and Szabo, 2020; Zhang et al., 2021). The physiological concentration of H2S ranges from 0.01 to 3 μM at the cellular level and 30–100 μM in serum (Wallace, 2007). H2S plays an indispensable role in physiological processes, for example, angiogenesis, neurotransmission, apoptosis, and insulin secretion (Austgen et al., 2011; Papapetropoulos, 2016; Bełtowski et al., 2018; Wang et al., 2020). Furthermore, aberrant H2S levels are strongly related to various pathophysiological processes, such as neurodegenerative diseases, liver cirrhosis, inflammation, and cancer (Kamoun et al., 2003; Chan and Wong, 2017; Wei et al., 2017; Bełtowski et al., 2018; Disbrow et al., 2021; Kushkevych et al., 2021; Ngowi et al., 2021). Hence, exploring validated assays for H2S is essential to better understand and diagnose their pathophysiological processes.
Compared with traditional imaging methods, including magnetic resonance imaging (MRI), computed tomography (CT) and ultrasound imaging (Poelma, 2016; Lim et al., 2019; Antequera et al., 2021), fluorescence imaging technology allows non-invasive detecting biomarkers with high sensitivity, quick response time and wonderful spatiotemporal resolution, which makes animal models of tracking pathology and clinical studies very attractive (Jun et al., 2020; Hanaoka et al., 2022; Qi et al., 2022; Sun et al., 2022). Fluorescence-based imaging typically uses small molecule fluorescent probes that are designed to bind/react with disease-based target biomarkers and offer measurable fluorescent signal changes for qualitative and quantitative analysis of analytes and imaging traces (Jia et al., 2022; Zhao L et al., 2022; Hou et al., 2022; Hou et al., 2020a; Gardner et al., 2021; Du et al., 2023; Li et al., 2023). Typically, these probes should exhibit wonderful sensitivity and specificity for biomarkers to guarantee their accurate detection in bio-systems (Hou et al., 2020b; He et al., 2021; Kawai et al., 2021; Ren M et al., 2021).
This work systematically reviews the research progress of H2S-based fluorescent probes in pathophysiological processes imaging and classifies fluorescent probes according to pathophysiological models (neurodegenerative diseases, inflammation, oxidative stress, cell apoptosis, organ injury, and diabetes), and introduces in detail the methods, means and design ideas for constructing various disease models (Figure 1). The design tactics, optical properties, response mechanism, and potential applications of these probes are discussed (Figure 2). Furthermore, we mainly focus on the biological application and significance of H2S in pathophysiological pathological processes. Finally, we discuss the progress and insufficiencies of reported fluorescent probes for H2S-related pathophysiological processes imaging and provide our insights on how to overcome these limitations. Hence, this paper will offer new thoughts and strategies for the development of novel fluorescent probes fitting for early warning of H2S-related pathophysiological processes.
FIGURE 1
FIGURE 2
2 Design strategy for H2S fluorescent probes
To meet the requirements of biological applications, H2S-based fluorescent probes for assessing pathophysiological processes-relevant should satisfy the following requirements: 1) Noteworthy signal changes after identification of H2S, and prefer fluorescence enhancement change or ratiometric fluorescence changes to reduce background noise and maximize spatial resolution; 2) fluorophores with excellent photostability, high fluorescence quantum yield, and wonderful biocompatibility; 3) the ideal fluorescent probe should respond quickly to H2S with wonderful selectivity and sensitivity; 4) organic solvents used as little as possible, because it will damage the function of biomolecules; 5) the identification system of the probes should be silent to biomarkers, for example, HEPES (4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid) buffers react easily with hypochlorous acid (HOCl) (Xing et al., 2016).
3 H2S-based imaging of fluorescent probe pathophysiological processes models
3.1 Neurodegenerative diseases imaging
3.1.1 Alzheimer’s disease imaging
Alzheimer’s disease (AD) is an age-related neurodegenerative disorder that can lead to dementia, usually affecting people over the age of 60 (Morales et al., 2014). The aggregation of amyloid-beta (Aβ) aggregates in the central nervous system may cause and exacerbate AD, and breaking down or stopping the formation of Aβ aggregates is a vital challenge in overcoming AD (Wood, 2017; Cao L et al., 2018; Starling, 2018; Lin et al., 2019). H2S donor, such as sodium sulfide (Na2S), reduces the generation of Aβ, thereby providing neuroprotection against Aβ aggregates and alleviating AD (Kshirsagar et al., 2020; Tabassum et al., 2020).
Mitochondria have been used as therapeutic targets for AD (Reddy, 2009; Wang and Chen, 2016; Swerdlow, 2018). In 2018, Li et al. reported a mitochondria-targeting bifunctional fluorescent probe 1 for studying the behavior between viscosity and H2S in mitochondria (Li et al., 2018). A significant green fluorescence enhancement was found at approximately 510 nm after the introduction of H2S. Figure 3A showed the cross-talk influence of H2S and viscosity in cellular mitochondria: The enlargement in viscosity may result in the reduction in H2S, while the increase in H2S might lead to the decrease in viscosity. This will be helpful for understanding the pathogenesis of AD.
FIGURE 3
Cu2+ accumulation or H2S deficiency is closely related to AD (Cui W et al., 2016; Vandini et al., 2019). In 2019, Ma et al. reported an “OFF-ON-OFF” fluorescent probe 2 for reversible testing Cu2+ and H2S. Probe 2 could be used to track Cu2+ and H2S sequentially and reversibly through changes in its fluorescence signal at 580 nm. Probe 2 exhibited extremely low cytotoxicity and excellent membrane permeability. Figure 3B showed that with increasing Cu2+ concentration, the fluorescence in mice was significantly enhanced, while it disappeared upon the addition of H2S. In addition, the probe had the potential ability to disassemble Cu2+-induced Aβ aggregates.
Aggregation-induced emission (AIE)-based probes have wonderful features owing to their tunable emission, favorable biocompatibility, and outstanding photophysical properties (Liu and Tang, 2020; Wu and Liu, 2021; Dai et al., 2022; Li Z et al., 2022). In 2022, Ramya et al. reported a tetraphenylethylene (TPE) “double-locked” fluorescent probe 3. The TPE fluorophore served as the core structure of AIEgen, 7-nitro-1,2,3-benzoxadiazole (NBD) acted as the recognition site for H2S, and the disulfide donor generated H2S in the presence of Cys or GSH. Probe 3 had the advantages of water solubility, low detection limit, and good selectivity for H2S. Figure 3C displayed that the structure of probe 3 could act as an H2S donor for subsequent depolymerization of Aβ1-42 protein, limiting the development of AD. In the presence of probe 3, the toxic aggregated Aβ1-42 peptide became non-toxic disaggregated Aβ1–42. Fluorescent probes with a “double-lock” sequential activation strategy have higher specificity and accuracy compared to the previous “single-lock” probe strategies (Liu et al., 2019).
3.1.2 Parkinson’s disease imaging
Parkinson’s disease (PD) is characterized by progressive loss of dopaminergic neurons in the substantia nigra (SN) (Hirsch et al., 1988). The first sign of cognitive impairment is memory loss, and then behavioral disturbances (Gagliardi and Vannini, 2022). It has been reported that H2S, as an antioxidant, has protective effects on PD by scavenging highly reactive oxygen species (ROS) as an antioxidant (Kimura and Kimura, 2004; Kimura et al., 2005). As well, overexpression of CBS or use of H2S donors offers neuroprotection in a 6-hydroxytryptamine (6-OHDA)-induced PD model (Yin et al., 2017; Cao X et al., 2018). Therefore, studying the pathogenesis of PD will be helpful for early therapy and intervention to slow down the progression of PD in the elderly.
Two-photon microscopy (TPM) exhibits many wonderful merits, including larger penetration depth (>500 μm), localization of excitation, and longer observation time (Xu et al., 2020; Juvekar et al., 2021). In 2013, Kim’s group reported a ratiometric two-photon (TP) fluorescent probe (4) for testing H2S in mitochondria, in which 6-(benzo[d]thiazol-2′-yl)-2-(methylamino)naphthalene was used as the probe fluorophore, 4-azidobenzyl carbamate was served as the recognition site for H2S, and triphenylphosphonium salt could be used as the mitochondrial targeting moiety (Bae et al., 2013). When H2S was added, the emission peaks of probe 4 were red-shifted from 464 to 545 nm. As shown in Figure 4A, the decrease of H2S and decrease of CBS expression were observed in studies involving the PD gene DJ-1, in which the decrease of H2S in astrocytes may facilitate the progress of PD.
FIGURE 4
Mitochondria, as an important organelle, provides energy for cells, and mitochondrial dysfunction is closely related to PD (Greenamyre, 2018; Grunewald et al., 2019; Doric and Nakamura, 2021). In 2020, Fang and coworkers obtained a TP fluorescent probe 5, using N,N-disubstituted unit as electron donors and pyridine cation as an electron-withdrawing group, which was used for testing mitochondrial viscosity and H2S (Fang et al., 2020). After different concentrations of H2S were introduced, the green fluorescence increased significantly. dl-Propargylglycine (PAG, a specific inhibitor of endogenous production of H2S)-induced PD Drosophila brains model had higher viscosity and lower H2S in mitochondria compared to the normal model (Figure 4B).
Although probe 5 has wonderful selectivity, fine sensitivity, and low detection limit for H2S, azide, the recognition group of the probe, can be decomposed by UV light, so false signals may be generated. In 2021, Shen and coworkers created a bifunctional near-infrared fluorescence (NIR) probe (6), which used dicyanoisopherone as the fluorescence core and 2,4-dinitrobenzenesulfonyl ether as the recognition group of H2S. Probe 6 had high photostability and a large stokes shift (110 nm). As the augment of H2S concentration, the fluorescence signal around 650 nm increased 20-fold. Moreover, the fluorescence signal of probe 6 around 580 nm changed with increasing viscosity. The changes in H2S levels and viscosity were investigated through the experiments of a zebrafish PD model induced by rotenone (a drug to reduce dopamine levels of zebrafish) (Figure 4C). The results showed that both viscosity and H2S increased in the zebrafish PD model.
Fluorescent probes employing a “double-lock” sequential activation strategy have higher specificity and accuracy compared to single-site release fluorescence (Liu et al., 2019). In 2021, a “double-locked” fluorescent probe 7 for monitoring H2S in high-viscosity systems was obtained by Kong and coworkers (Kong et al., 2021). In high-viscosity environments (the first “key”), 2,4-dinitrobenzenesulfonate group (the second “key”) in probe 7 was recognized with H2S, and the fluorescence signal around 630 nm was enhanced 50-fold. As shown in Figure 4D, experiments of detecting H2S and viscosity in glutamate (a neurotoxin)-induced PD PC 12 cell model were conducted. The results showed that the level of H2S as an antioxidant was upregulated to reduce oxidative stress in glutamate-induced PC12 cells.
Response time is one of the important indicators for the evaluation of probes in biological applications. As shown in Table 1, the reported H2S fluorescent probes for PD imaging were slow (15–120 min). In 2022, Li S et al. (2022) reported a bifunctional fluorescent probe (8) to detect viscosity and H2S in mitochondria. As viscosity gradually increased, the fluorescence signal of probe 8 around 730 nm was increased. The probe reached a response plateau after the addition of H2S for 8 min, with a 6-fold amplification of the fluorescence signal around 516 nm. Probe 8 was successfully applied to test the viscosity behavior of a PD model (PC-12 cells treated with glutamate), in which both H2S and viscosity increased in PD. As shown in Figure 4E, after injection of nystatin or glutamate in nude mouse tumor models, the red fluorescence enhanced notably with time.
TABLE 1
| Probe | Pathophysiological models | LOD | λex/λem (nm) | Response time | Recognition system | Comment | Real sample | References |
|---|---|---|---|---|---|---|---|---|
| 1 | Alzheimer’s disease | 0.17 μM | 370/510 | 30 min | PBS buffer solution (pH = 7.4) | Dual-response (viscosity and H2S); mitochondrial targetable; increase in fl. intensity (up to 7-fold) | Living cells | Li et al. (2018) |
| 2 | Alzheimer’s disease | 14.8 nM | 540/580 | — | PBS buffer solution (pH = 7.4, containing 50% EtOH) | Dual-response (Cu2+ and H2S) | Living cells and living mice | Ma et al. (2019) |
| 3 | Alzheimer’s disease | 0.1 μM | 364/480 | — | HEPES buffer solution (pH = 7.4, containing 10% THF) | AIE-fluorescence; “double-locked”; increase in fl. intensity (up to 12-fold) | Living cells and living mice | Ramya et al. (2022) |
| 4 | Parkinson’s disease | 0.4 μM | 340/500, 420 | 60 min | HEPES buffer solution (30 mM, pH = 7.4, containing 100 mM KCl) | Two-photon; mitochondrial targetable probe; ratiometric I500/I420 | Living cells and tissue | Bae et al. (2013) |
| 5 | Parkinson’s disease | 11.66 nM | 480/585 | 120 min | PBS buffer solution (pH = 7.4, containing 50% DMSO) | Dual-response (viscosity and H2S); mitochondrial targetable; increase in fl. intensity | Living cells, tissue, and drosophila brains | Fang et al. (2020) |
| 6 | Parkinson’s disease | 79 nM | 540/650 | <15 min | PBS buffer solution (pH = 7.4, containing 1% DMSO) | Dual-response (viscosity and H2S); large stokes shift (110 nm); NIR imaging; increase in fl. intensity (up to 20-fold) | Living cells, tissue, and living zebra fishes | Shen et al. (2021) |
| 7 | Parkinson’s disease | 0.1 μM | 460/630 | — | PBS buffer solution (pH = 7.4, containing 10% glycerol) | Dual-response (H2S and viscosity); “double-locked”; increase in fl. intensity (up to 63-fold) | Living cells | Kong et al. (2021) |
| 8 | Parkinson’s disease | — | 385/516 | 8 min | PBS buffer solution (pH = 7.4, containing 30% DMSO) | Dual-response (viscosity and H2S) | Living cells and living mice | Li S et al. (2022) |
| 9 | Stroke | 1.3 nM | 450/670 | 40 min | PBS buffer solution (pH = 7.4, containing 80% glycerol and 2% DMSO) | NIR imaging; increase in fl. intensity (up to 25-fold) | Living cells and living mice | Liang et al. (2022) |
| 10 | Inflammation | 18.8 nM | 400/540 | 10 min | PBS buffer solution (10 mM, pH = 7.4, containing 1% DMSO) | Two-photon; increase in fl. intensity (up to 258-fold) | Living cells and tissue | Ou et al. (2021) |
| 11 | Inflammation | 0.74 μM | 440/561 | 60 min | PBS buffer solution (10 mM, pH = 7.4, containing 1% DMSO) | Two-photon; increase in fl. intensity (up to 38.1-fold) | Living cells, tissue, and living mice | Ding et al. (2022) |
| 12 | Inflammation | 19 nM | 530/663 | 3 min | PBS buffer solution (10 mM, pH = 7.4) | NIR imaging; large Stokes shift (141 nm); mitochondrial targetable; increase in fl. intensity (up to 27-fold) | Living cells, living zebra fishes, and living mice | Gong et al. (2021) |
| 13 | Inflammation | 13 nM | 540/699 | 4 min | PBS buffer solution | NIR imaging; large Stokes shift (155 nm); increase in fl. intensity (up to 75-fold) | Living cells, living zebra fishes, and living mice | Wang K et al. (2022) |
| 14 | Inflammation | 1.8 μM | 425/596 | 10 min | PBS buffer solution (20 mM, pH = 7.4, containing 30% DMF) | Colorimetric; increase in fl. intensity (up to 34-fold) | Living cells and living mice | Hu et al. (2021) |
| 15 | Inflammation | 310 nM | 565/620 | 120 s | PBS buffer solution | Mitochondrial targetable, increase in fl. intensity (up to 234-fold) | Living cells, living zebra fishes, and living mice | Wang WX et al. (2022) |
| 16 | Apoptosis | 31 μM | 450/540 | 15 min | PBS buffer solution (pH = 7.4, containing 30% DMF) | Dual-response (copper II) and H2S); increase in fl. intensity (up to 40-fold) | Living cells, and living zebra fishes | Ren M et al. (2021) |
| 17 | Apoptosis | — | 450/550 | 45 min | — | Membrane permeability; specific imaging of cancer cells; increase in fl. intensity | Living cells | Singh et al. (2021) |
| 18 | Apoptosis | 64 nM | −/550 | 30 min | PBS buffer solution (20 mM, pH = 7.4, containing 5% DMSO) | Increase in fl. intensity | Living cells | Liu et al. (2022) |
| 19 | Oxidative Stress | 9 μM | −/535 | 120 min | PBS buffer solution (50 mM, pH = 7.4, containing 0.007% BSA, 100 μM NADH) | Dual-response (hNQO1 and H2S); “double-locked”; increase in fl. intensity (up to 400-fold) | Living cells | Zhang et al. (2019) |
| 20 | Oxidative Stress | 0.11 μM | 390/515 | 30 min | PBS buffer solution (10 mM, pH = 7.4, containing 20% DMSO) | Golgi targetable, increase in fl. intensity | Living cells and living zebra fishes | Zhu et al. (2020a) |
| 21 | Oxidative stress | 0.10 μM | 440/550 | 25 min | PBS buffer solution (10 mM, pH = 7.4) | Golgi targetable, increase in fl. intensity | Living cells and living zebra fishes | Zhu et al. (2020b) |
| 22 | Oxidative stress | 0.058 μM | 325/627, 413 | 80 min | HEPES buffer (20.0 mM, pH = 7.4, containing 1.0 mM CTAB) | Dual-response (H2O2 and H2S); two increased fluorescence signals | Living cells and living zebra fishes | Yang et al. (2020) |
| 23 | Oxidative stress | 44.6 nM | 460/550 | 10 min | PBS buffer solution (25 mM, pH = 7.4, containing 30% CH3CN) | Dual-response (H2O2 and H2S); mitochondrial targetable; “double-locked”; increase in fl. intensity | Living cells and living zebra fishes | Wang Y et al. (2022) |
| 24 | Oxidative stress | 39.1 nM | 480/560, 650 | 12 min | PBS buffer solution (10 mM, pH = 7.4, containing 10% DMSO) | NIR imaging; large Stokes shift (150 nm); endoplasmic reticulum targetable; ratiometric I650/I560 | Living cells and living zebra fishes | Shu et al. (2020) |
| 25 | Oxidative stress | 17.16 nM | 400/464 | — | PBS buffer solution (10 mM, pH = 7.4, containing 20% CH3CN) | Dual-response (ONOO− and H2S); increase in fl. intensity | Living cells | Tang et al. (2021) |
| 26 | Organ injury | 192.1 nM | 360/445 | 15 min | PBS buffer solution (50 mM, pH = 7.4, containing 10% DMF) | Dual-response (HClO and H2S); two-photon; increase in fl. intensity | Living cells and tissue | Jiao et al. (2018) |
| 27 | Organ injury | 0.09 μM | 720/787 | 120 min | PBS buffer solution (20 mM, pH = 7.4, containing 5% DMSO) | NIR imaging; increase in fl. intensity (up to 52-fold) | Living cells, living mice , and lung organs | Su et al. (2022) |
| 28 | Diabetes | 33 nM | 600/633 | — | PBS buffer solution (20 mM, pH = 7.4) | NIR imaging; “double-locked”; increase in fl. intensity | Living cells and living mice | Li Z et al. (2022) |
Spectroscopic properties and pathophysiological models imaging of small molecular probes for detection of H2S.
3.1.3 Stroke imaging
Ferroptosis (iron-dependent oxidative stress) is closely associated with cancer, neurodegenerative diseases, ischemia-reperfusion injury, etc., and detecting its pathological processes is vital for disease prognosis and treatment (Qiu et al., 2020; Yu et al., 2021; Zhao et al., 2021; Lei et al., 2022; Zhao Y et al., 2022). In 2022, Liang and colleagues reported a NIR fluorescent probe (9) with H2S triggering and H2S releasing properties. Azidobenzene served as the H2S recognition site and was linked to the fluorophore via thiocarbamate (H2S precursor). When probe 9 reacted with H2S, carbonyl sulfide (COS) was released by 1,6-elimination reactions, and then H2S was released catalyzed by carbonic anhydrase (CA). In glycerol, probe 9 had a strong fluorescence signal at 646 nm. As the H2S concentration increased, the fluorescence signal around 670 nm increased approximately 25-fold. Moreover, the relationship between oxygen-glucose deprivation/re-oxygenation (OGD/R) and ferroptosis was studied with PC12 cells. Figure 5 showed that the process of cell ischemia-reperfusion was accompanied by ferroptosis and H2S depletion.
FIGURE 5
3.2 Inflammation imaging
Inflammation mainly includes two categories, infectious and non-infectious, manifested as swelling, redness, pain, fever, dysfunction, etc (Fontaine et al., 2016). Inflammation is usually beneficial to biological systems, and it is an automatic defense response of biological systems. However, sometimes inflammation can be harmful to tissues and organisms. For example, out-of-control inflammation can be responsible for cardiovascular and cerebrovascular diseases, fibrosis, and cancer (Capuron et al., 2008; Mantovani et al., 2008; Lim, 2018; Mack, 2018; Weiss, Ganz, and Goodnough, 2019). These diseases and inflammation are always mutually reinforcing (Jiang et al., 2019; Majd, Saunders, and Engeland, 2020; Liberale et al., 2022). Therefore, accurate diagnosis at the initial stages of inflammation and preventing the further development of inflammation into more severe diseases is important. H2S can achieve anti-inflammatory effects by inhibiting the production of inflammatory cytokines, and its overexpression in vivo has been considered as a biomarker of all kinds of inflammation. So, it is vital to investigate the behaviors or relationships between H2S and inflammation in biological systems.
Lipopolysaccharide (LPS), as a dominating cell surface component of Gram-negative bacteria, can be used for bioimaging to induce cellular inflammation models (Lykhmus et al., 2016). In 2021 and 2022, Ou et al. (2021), Ding et al. (2022) fabricated TP fluorescence probes (10, 11) for H2S imaging in inflammatory models, respectively. Probe 10 consisted of naphthalimide derivative as a fluorophore and 4- dinitrophenyl ether (DNB) as a recognition group. When H2S existed, probe 10 exhibited amazing fluorescence enhancement (258-fold) at 540 nm. Figure 6A showed that compared with normal tissues, the inflamed tissues had a significant fluorescence signal augmentation in the green channel. Probe 11 consisted of azide and a fluorophore of naphthylimide. When H2S was introduced, the fluorescence signal around 561 nm was enhanced 38.1-fold. In addition, probe 11 exhibited excellent TP fluorescence properties in cells and liver tissues, penetrating to depths of 126 μm in liver tissue. As shown in Figure 6B, the experiment of the LPS-induced air pouch inflammation model was conducted to observe the development of inflammation and the behavior of H2S.
FIGURE 6
In 2021 and 2022, Gong’s group and Wang’s group fabricated NIR mitochondrial-targeting fluorescent probes (12, 13) for H2S imaging in inflammatory models, respectively. In probe 12, the pyridium unit (positively charged) acted as a mitochondria-targeting group and dinitrophenyl (DNP) ether as an H2S recognition group. When H2S was added, a fluorescence-enhancing signal around 663 nm appeared. Probe 12 had the advantages of wonderful water solubility, fast response (<3 min), and large Stokes shift (141 nm). As shown in Figure 6C, changes in H2S concentration were performed during LPS-induced inflammation in mice. The results suggested that more H2S could be produced during inflammation. Probe 13 consisted of a NIR fluorophore and a recognition group (NBD). After H2S was introduced, probe 13 showed a remarkable enhancement (75-fold) in fluorescence signal at 699 nm. Probe 13 exhibited a large Stokes shift (155 nm), quick response (4 min), and wonderful selectivity for H2S. Probe 13 could detect exogenous and endogenous H2S in live cells and zebrafish, respectively. Figure 6D showed that probe 13 was used to monitor H2S fluctuations in LPS-induced inflammatory cells and mice.
Colorimetric detection can be recognized by the naked eye. In 2021, Hu et al. (2021) developed a phenothiazine-based colorimetric fluorescence probe (14) to selectively detect H2S in an LPS-induced inflammation mouse model. Probe 14 was based on a donor–π–acceptor (D–π–A) structure that coupled phenothiazine to rhodanine derivative via a carbon-carbon double bond. During the probe’s identification of H2S, the fluorescence signal around 596 nm showed a significant increase (34-fold). Probe 14 was able to visualize exogenous and endogenous H2S in vitro and in vivo (zebrafish and nude mice). Figure 6E showed that visualization of the production of H2S in inflammatory models has been realized by probe 14.
Rhodamine dyes are attracting attention for their wonderful photostability, long emission wavelength, convenient synthesis, and high quantum yield (Rajasekar, 2021). In 2022, Wang and coworkers created a mitochondrial-targeting fluorescent probe 15 to test the changes in H2S concentration. The fluorescence intensity around 620 nm progressively augmented about 234-fold with increasing H2S concentration. Probe 15 had some wonderful features of fast response (120 s), low detection limit (310 nM), and excellent sensitivity. Probe 15 could monitor exogenous and endogenous H2S in HeLa cells and zebrafish, respectively. Probe 15 could be used to visually detect H2S in LPS-induced mouse inflammation experiments (Figure 6F). And probe 15 was appropriate for testing the behavior of H2S in human plasma samples.
3.3 Apoptosis imaging
Apoptosis is caused by pathological and physiological conditions triggered by extracellular death receptor ligation or DNA damage and/or cytoskeletal disruption (Akçapınar et al., 2021). The intrinsic way of apoptosis is triggered by the cell’s response to injury, while the external way is triggered by cell-stimulated death receptors of the immune system (Sica et al., 1990; Oppenheim et al., 2001). When caspase 3 is activated, both pathways converge, leading to cell death (D’arcy, 2019). Timely monitoring of apoptosis is helpful for early warning and therapy of related pathophysiological processes and the continuous assessment of drug effectiveness. H2S has been found to protect cells: H2S can prevent Abeta-induced neuronal apoptosis by diminishing mitochondrial translocation of phosphatase and tensin homolog deleted on chromosome ten (PTEN) (Cui Z et al., 2016); H2S can restrain cell apoptosis and protect bronchial epithelium in a mouse model of allergic inflammation (Mendes et al., 2019); H2S improves LPS-induced memory disorder in mice by decreasing apoptosis, oxidation, and inflammatory effects (Kshirsagar et al., 2021). However, H2S can also promote apoptosis: H2S contributes to LPS-induced osteoblast apoptosis by restraining the AKT/NF-κB signaling pathway (Wang et al., 2020); H2S, which releases whey protein derivatives, induces apoptosis through extrinsic and intrinsic pathways (Li et al., 2020). Therefore, the exact relationship between H2S and apoptosis needs to be further studied.
Cu/NaHS significantly reduced the Menkes copper transport (ATP7A) protein levels, promoted intracellular Cu accumulation, and resulted in increased Cu cytotoxicity (Goto et al., 2020). Therefore, continuous detection of H2S and Cu2+ is helpful to understand their interaction. In 2021, a bifunctional fluorescent probe (16) for testing H2S and Cu2+ in different channels in live cells and zebrafish was reported by Ren and colleagues. Naphthalimide and rhodamine were used as probe fluorophores, and azide and hydralazine were selected as recognition sites for H2S and Cu2+. The fluorescence intensity augmented 40-fold and 31-fold in response to H2S and Cu2+, respectively. Probe 16 allowed simultaneous fluorescence imaging of H2S and Cu2+ in cells, enabling visualization of H2S-enhanced Cu2+ cytotoxicity (Figure 7A).
FIGURE 7
In 2021, Singh et al. fabricated a naphthalimide-based bifunctional fluorescent probe 17 for detecting H2S, which was made up of a peptide-naphthalimide fluorophore and an H2S sensing moiety. When H2S was introduced, the morphology of probe 17 showed the combination of fibrous “bushes” with bright yellow fluorescence. Probe 17 had the ability of cancer cell imaging and induction of apoptosis in the meantime, which could be a good candidate for the theranostic agent (Figure 7B).
Because of its fascinating optical properties, including large Stokes shift, “turn-on” fluorescence, relatively high quantum yield, and good photostability, 3-hydroxyflavone has been widely concerned by researchers (Sedgwick et al., 2018; Wang, Lai, Qiu and Liu, 2019; Doric and Nakamura, 2021). In 2022, Liu et al. (2022) created a fluorescent probe 18 based on excited state intramolecular proton transfer (ESIPT) for testing H2S. The probe consisted of 3-hydroxyflavone and 4-Chloro-7-nitro-1,2,3-benzoxadiazole (NBD-Cl, H2S-specific recognition unit). When H2S existed, 3-hydroxyflavone formed a ketone tautomer and released fluorescence at 550 nm. Figure 7C showed the behavior of different concentrations of H2S on the apoptosis of MCF-7 cells.
3.4 Oxidative stress imaging
The imbalance between oxidants and antioxidants is beneficial to oxidants and can cause damage, known as oxidative stress (Sies, 1997). Oxidants are normal products of aerobic metabolism, but they can be produced at a higher rate under pathophysiological conditions. If left unchecked, oxidative stress can lead to damage to DNA, proteins, and lipids, and ultimately cell death (Greenwood and Witney, 2021). H2S has been proven to influence cellular redox through multiple mechanisms, such as ROS scavenging, protein modification, mitochondria, and respiratory oxidation (Pal, Bandyopadhyay, and Singh, 2018; Scammahorn et al., 2021). Furthermore, some suborganelles are related to oxidative stress, for example, the Golgi apparatus actively participates in the stress response, and when larger than the stress threshold, the Golgi apparatus can simultaneously activate cell repair and apoptosis mechanisms (Hicks and Machamer, 2005; Wlodkowic, Skommer, Mcguinness, Hillier, and Darzynkiewicz, 2009); H2S can effectively decrease endothelial-mesenchymal conversion by restraining ER stress (Ying et al., 2016). Therefore, tracking H2S behaviors in different organelles is crucial for the research and treatment of related diseases or pathophysiological processes.
H2S and human NAD(P)H:quinine oxidoreductase 1 (hNQO1), as latent cancer biomarkers, were able to participate in cell redox homeostasis (Park, et al., 2021). In 2019, Zhang et al. (2019) developed a dual biomarker (H2S and hNQO1)-triggered fluorescent probe to reveal the synergistic antioxidant effect under oxidative stress. Quinone propionic acid (Q3PA) and NBD served as hNQO1 and H2S recognition units, and coumarin and naphthalimide acted as fluorophores of probe 19, respectively. The strategy of dual reaction and dual quenching was formed, which improved the sensitivity and selectivity of the probe. When H2S existed, the fluorescence signal of probe 19 was remarkably enhanced (400-fold) at 535 nm. In addition, the probe could simultaneously test the endogenous H2S and hNQO1 activities in organic systems. Figure 8A showed that HeLa cells could induce the production of endogenous H2S under the existence of exogenous hydrogen peroxide (H2O2), that is, H2S played a synergistic antioxidant role under oxidative stress.
FIGURE 8
The Golgi stress response is activated when Golgi function is inadequate compared to cellular demands (Gao, et al., 2021). Golgi apparatus provides cytoprotection by moderating the synthesis and metabolism of bioactive molecules in response to conventional stress (Paul, et al., 2014; Hirayama, et al., 2019). In 2020, Zhu et al. (2020), Shu et al. (2020) reported Golgi-targeted fluorescent probes (20, 21) detecting H2S, respectively. In probe 20, 4-CF3-substituted 7-aminoquinoline was used as fluorophore, and azide was elected as the specific identification group of H2S. The introduction of trifluoromethyl into the quinoline structure facilitated the entry of the probe into the Golgi apparatus through the membrane barrier. With the H2S concentration increased, the fluorescence signal around 515 nm was augmented. As shown in Figure 8B, probe 20 has achieved in situ display of H2S generation under monensin-induced Golgi pressure. In probe 21, 1,8-naphthalimide was used as the fluorophore, azide was used as the identification group of H2S, and phenylsulfonamide was used as the targeting group of the Golgi apparatus. When H2S was introduced, the fluorescence signal was remarkably enhanced at 550 nm. Furthermore, Figure 8C showed probe 21 could be seen as a chemical method to detect the behavior of H2S in situ during Golgi stress, thus confirming that H2S could be used as a biomarker to investigate Golgi stress.
Intracellular H2S and H2O2 are closely associated with maintaining cellular homeostasis, and their levels directly reflect the degree of oxidative stress and disease (Kimura and Kimura, 2004; Kimura, et al., 2009). In 2020, Yang et al. (2020) fabricated a fluorescent probe 22 for testing dynamic H2O2/H2S redox processes in organisms. Phenylboronate and azide moieties served as recognition units for H2O2 and H2S, respectively. Under the existence of H2O2, the fluorescence intensity around 413 nm declined, while the fluorescence around 486 nm enhanced remarkably. When H2S was added, two fluorophores (HCB and TQC) were released, and the fluorescence at 413 and 627 nm were emitted, respectively. Figure 8D showed phorbol 12-myristate 13-acetate (PMA)-induced stress experiments, in which cells produced H2O2 and reduced H2S. In 2022, Wang and colleagues obtained a NIR fluorescence probe activated by H2O2 to monitor the changes in H2S during oxidative stress. When H2O2 was present, the fluorescence signal of probe 23 blue-shifted from 700 to 550 nm after recognizing H2S. Probe 23 could monitor the changes in H2S during the oxidation-triggered oxidative stress process in cells and zebrafish. Figure 8E showed that the probe evaluated the up-regulation of H2S levels based on oxidative stress by H2O2/PMA.
The endoplasmic reticulum (ER) plays a critical role in protein synthesis, folding, distribution, and storage of calcium ions (BÁnhegyi, et al., 2007; Pagliassotti, et al., 2016). ER stress can result in autophagy and even cell death, which is bound up with serious diseases or pathophysiological processes (Holczer, et al., 2018). In 2020, Shu et al. (2020) reported an ER-targeted ratiometric fluorescent probe for detecting H2S in organism systems. Probe 24 was composed of dicyanoisophorone analogue with a large Stokes shift and o-carboxybenzaldehyde as the specific recognition group of H2S. H2S reacted with the aldehyde group in the probe through nucleophilic addition, emitting fluorescence at 650 nm. The probe had good selectivity, large Stokes shift (150 nm). Figure 8F showed that the probe observed the endogenous changes in H2S under tunicamycin-induced endoplasmic reticulum stress.
Abnormal metabolism of organisms produces high concentrations of active carbonyl substances, leading to carbonyl stress, which leads to cell injury or cell apoptosis (Bordoni, et al., 2006). Therefore, the development of tools to image carbonyl stress is essential to decrease its damage and explore new drug treatments or reduce carbonyl stress. In 2021, a visualized fluorescent probe (25) for monitoring the protective effect of endogenous H2S during carbonyl stress in endothelial cells was developed by Tang and colleagues. The probe had dual fluorophores (rhodamine and coumarin fluorophores) and dual recognition sites (phenylhydrazine and 2,4-dinitrobenzenesulfonyl ether) to achieve the purpose of dual recognition of H2S and ONOO−, and the fluorescence signals of rhodamine and coumarin would not interfere with each other (>100 nm). When H2S and ONOO− were introduced, the probe showed remarkable increases in fluorescence signal around 464 and 570 nm, respectively. Probe 25 enabled endogenous H2S and ONOO− imaging in different channels. Figure 8G showed that probe 25 was suitable for visualizing the protective effect of endogenous H2S during carbonyl stress.
3.5 Organ injury imaging
H2S is synthesized in almost all organ systems (Kasinath et al., 2018). H2S has been proven to protect against organ damage, including liver damage, heart damage, kidney damage, etc (Tan et al., 2011; Wang et al., 2012; Kasinath, 2014). For example, in acute or chronic kidney disorders, H2S generation from the renal cells is decreased (Koning et al., 2015; Lobb et al., 2015; Cao and Bian, 2016; Cao et al., 2019); Endogenous and exogenous H2S reduces myocardial damage and improves cardiac function (Johansen et al., 2006; Wu et al., 2021); Decreased levels of endogenous H2S in the brain were associated with increased lesion volume and mortality after traumatic brain injury (TBI) (Zhang et al., 2013); H2S prevents LPS-induced acute lung injury (ALI) by restraining synergistic pro-inflammatory and oxidative reactions of stress proteins, mitogen-activated protein kinases (MAP kinases), and ROS signaling pathways (Zimmermann et al., 2018). Therefore, the development of sensitive probes for in vivo imaging of H2S is critical for exploring H2S biology and the diagnosis of organ injury.
In 2018, Jiao’s group developed a TP fluorescent probe 26, which was used to explore the potency of HClO as an indicator of drug-induced liver injury (DILI) and the detoxification of N-acetylcysteine (NAC) mediated by H2S. The probe was linked by 7-amino coumarin and rhodamine B via piperazine. When HClO or H2S existed, the fluorescence signal was remarkably enhanced at 580 or 445 nm. In this process, the recovery of the D-π-A structure induced by azide reduction of H2S and the ring opening induced by HClO were carried out separately, so that H2S and HClO did not generate signals that interfered with each other. As shown in Figure 9A, DILI induced by antidepressants such as duloxetine and fluoxetine and their remission were assessed at the cellular and tissue levels, respectively. The data showed that only after combined administration of the drugs, a significant increase of HClO and significant liver injury were found. At the same time, NAC pretreatment led to an increase in endogenous H2S levels, which was helpful in the remission of DILI.
FIGURE 9
Hemicyanine dyes have great potential in the research of small animal imaging and disease modeling owing to their emission in the NIR regions, convenient synthesis, and wavelength tunability (Li H et al., 2022). In 2022, a NIR fluorescent probe 27 based on sulfur-substitution hemicyanine dye for H2S recognition was obtained by Su and colleagues. In contrast to traditional hemicyanine dyes, the oxygen in oxygen-substitution hemicyanine dyes was substituted by sulfur to become sulfur-substitution hemicyanine dyes. 2,4-dinitrophenyl served as the identifying site for H2S and the quenching group for probe fluorescence. As H2S concentration increases, the fluorescence signal around 787 nm was markedly increased (52-fold), red-shifted by 60 nm compared to oxygen-substituted hemicyanine dyes. As shown in Figure 9B, in the mouse model experiment of LPS-induced acute lung injury, the data showed a significant increase in H2S concentration.
3.6 Diabetic imaging
Diabetes, as a disease characterized by hyperglycemia, is related to diverse complications, including cardiovascular disease, stroke, kidney failure, neuropathy, retinopathy, and amputation (Al-Sofiani et al., 2019; Lau et al., 2019; Buades et al., 2021; Sempere-Bigorra et al., 2021; Milluzzo et al., 2021; O’neill et al., 2017). It is reported that diabetes can be divided into three types: Gestational diabetes, type 1 diabetes (T1D), and type 2 diabetes (T2D) (Xiang et al., 2018). H2S, as a promising candidate, helps to prevent and therapy of diabetes (Sun et al., 2021). Compared to lean participants, overweight and T2D patients had significantly lower blood levels of H2S (Whiteman et al., 2010). The protein expression and activity of CSE were significantly higher in peripheral blood mononuclear cells of normal humans than T1D patients (Manna et al., 2014). Therefore, studying the relationship between H2S and diabetes in-depth may be helpful to develop potential treatments for diabetes.
In 2022, a “double-locked” fluorescent probe 28 with NIR emission for examining the H2S levels in organisms was obtained by Wei and colleagues. Probe 28 consisted of a fluorophore with NIR emission (rhodamine B), and re-active units of H2S (aromatic azide and NBD-piperazine). The fluorescence around 663 nm was locked and quenched through the intramolecular charge transfer (ICT) and photoinduced electron transfer (PET) processes. Probe 28 exhibited good selectivity and excellent sensitivity for imaging the behaviors of H2S. In addition, probe 28 was applied to image the levels of endogenous H2S in IR-Hepg2 cells and diabetic mice (Figure 10).
FIGURE 10
4 Summary and outlook
Fluorescence imaging may become a universally accepted diagnostic modality in the future due to its high efficiency and low cost. Accurate detection of H2S associated with pathophysiological processes and examining their behaviors are essential for understanding the diseases or pathophysiological processes involved, especially in the early stages. This paper reviews the bioimaging of H2S in pathophysiological processes (neurodegenerative diseases, inflammation, apoptosis, oxidative stress, organ injury, and diabetes) with fluorescent diagnostic probes. The design strategies, recognition mechanisms, optical properties, and applications of H2S fluorescent probes in bioimaging are further discussed. Up to now, remarkable progress has been achieved in exploring organic fluorescent probes for examining and studying H2S-associated pathophysiological processes in real-time.
Although delightful progress has been obtained, there are still some issues that need to be improved and solved: 1) Most fluorescent probes are inherently monochromatic, which can easily lead to false-positive signals in complex physiological settings, resulting in incorrect disease diagnosis; 2) Most H2S fluorescent probes reported to date have fluorescence emission wavelengths in the UV-visible region, which limits their application in studying diseases. There is still a large lack of H2S-based organic fluorescent probes that can be applied for routine diagnosis and monitoring of clinical diseases or pathophysiological processes. So it is crucial and urgent to construct novel fluorescent probes with fascinating advantages for imaging H2S associated with pathophysiological processes. To achieve this goal, we can start from the following aspects: 1) Designing fluorescent probes with excellent properties, including high quantum yields, large Stokes shifts, large photostability, and fast response; 2) Exploring the fluorescent probes of H2S with fine tissue penetration and high spatial resolution, which may have the greatest application due to the depth of biological tissues; 3) Developing organic fluorescent probes in the NIR-II region, which is expected to facilitate the development of systems suitable for monitoring deep organ-related diseases.
Overall, organic fluorescent probes with wonderful features might have the ability to image H2S associated with pathophysiological processes. It is believed that organic fluorescent probes for imaging H2S in pathophysiological processes will become increasingly vital testing tools in the future.
Statements
Author contributions
T-TJ: writing—original draft; literature collection. YZ: literature collection. HN: literature collection; processing of pictures. J-TH: conceptualization; supervision; editing. SW: supervision; methodology. All authors contributed to the article and approved the submitted version. All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
Funding
This research was funded by the National Natural Science Foundation of China (No. 22207087) and the Natural Science Foundation of Henan (No. 222300420244).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AkçapınarR.GaripcanB.GoodarziV.UzunL. (2021). Designing of various biosensor devices for determination of apoptosis: A comprehensive review. Biochem. Biophys. Res. Commun.578, 42–62. 10.1016/j.bbrc.2021.08.089
2
Al-SofianiM. E.DerenbeckerR.QuartuccioM.KalyaniR. R. (2019). Aspirin for primary prevention of cardiovascular disease in diabetes: A review of the evidence. Curr. Diab. Rep.19, 107. 10.1007/s11892-019-1206-6
3
AntequeraT.CaballeroD.GrassiS.UttaroB.Perez-PalaciosT. (2021). Evaluation of fresh meat quality by hyperspectral imaging (HSI), nuclear magnetic resonance (nmr) and magnetic resonance imaging (MRI): A review. Meat Sci.172, 108340. 10.1016/j.meatsci.2020.108340
4
AugsburgerF.SzaboC. (2020). Potential role of the 3-mercaptopyruvate sulfurtransferase (3-mst)-hydrogen sulfide (H2S) pathway in cancer cells. Pharmacol. Res.154, 104083. 10.1016/j.phrs.2018.11.034
5
AustgenJ. R.HermannG. E.DantzlerH. A.RogersR. C.KlineD. D. (2011). Hydrogen sulfide augments synaptic neurotransmission in the nucleus of the solitary tract. J. Neurophysiol.106, 1822–1832. 10.1152/jn.00463.2011
6
BaeS. K.HeoC. H.ChoiD. J.SenD.JoeE. H.ChoB. R.et al (2013). A rratiometric two-photon fluorescent probe reveals reduction in mitochondrial H2S production in Parkinson's disease gene knockout astrocytes. J. Am. Chem. Soc.135, 9915–9923. 10.1021/ja404004v
7
BánhegyiG.BaumeisterP.BenedettiA.DongD.FuY.LeeA. S.et al (2007). Endoplasmic reticulum stress. Ann. N. Y. Acad. Sci.1113, 58–71. 10.1196/annals.1391.007
8
BełtowskiJ.WójcickaG.Jamroz-WiśniewskaA. (2018). Hydrogen sulfide in the regulation of insulin secretion and insulin sensitivity: Implications for the pathogenesis and treatment of diabetes mellitus. Biochem. Pharmacol.149, 60–76. 10.1016/j.bcp.2018.01.004
9
BordoniV.PiroddiM.GalliF.De CalM.BonelloM.DimitriP.et al (2006). Oxidant and carbonyl stress-related apoptosis in end-stage kidney disease: Impact of membrane flux. Blood Purif.24, 149–156. 10.1159/000089452
10
BuadesJ. M.CraverL.Del PinoM. D.Prieto-VelascoM.RuizJ. C.SalgueiraM.et al (2021). Management of kidney failure in patients with diabetes mellitus: What are the best options?J. Clin. Med.10, 2943. 10.3390/jcm10132943
11
CaoX.BianJ. S. (2016). The role of hydrogen sulfide in renal system. Front. Pharmacol.7, 385. 10.3389/fphar.2016.00385
12
CaoL.CaoX.ZhouY.NagpureB. V.WuZ. Y.HuL. F.et al (2018). Hydrogen sulfide inhibits ATP-induced neuroinflammation and Aβ1–42 synthesis by suppressing the activation of STAT3 and cathepsin S. Brain Behav. Immun.73, 603–614. 10.1016/j.bbi.2018.07.005
13
CaoX.CaoL.DingL.BianJ.-S. (2018). A new hope for a devastating disease: Hydrogen sulfide in Parkinson’s disease. Mol. Neurobiol.55, 3789–3799. 10.1007/s12035-017-0617-0
14
CaoX.ZhangW.MooreP. K.BianJ. (2019). Protective smell of hydrogen sulfide and polysulfide in cisplatin-induced nephrotoxicity. Int. J. Mol. Sci.20, 313. 10.3390/ijms20020313
15
CapuronL.SuS.MillerA. H.BremnerJ. D.GoldbergJ.VogtG. J.et al (2008). Depressive symptoms and metabolic syndrome: Is inflammation the underlying link?Biol. Psychiatry64, 896–900. 10.1016/j.biopsych.2008.05.019
16
ChanS. J.WongP. T. H. (2017). Hydrogen sulfide in stroke: Protective or deleterious?Neurochem. Int.105, 1–10. 10.1016/j.neuint.2016.11.015
17
CirinoG.SzaboC.PapapetropoulosA. (2022). Physiological roles of hydrogen sulfide in mammalian cells, tissues, and organs. Physiol. Rev.103, 31–276. 10.1152/physrev.00028.2021
18
CuiW.ZhangY.YangC.SunY.ZhangM.WangS. (2016). Hydrogen sulfide prevents abeta-induced neuronal apoptosis by attenuating mitochondrial translocation of PTEN. Neuroscience325, 165–174. 10.1016/j.neuroscience.2016.03.053
19
CuiZ.BuW.FanW.ZhangJ.NiD.LiuY.et al (2016). Sensitive imaging and effective capture of Cu2+: Towards highly efficient theranostics of alzheimer's disease. Biomaterials104, 158–167. 10.1016/j.biomaterials.2016.06.056
20
DaiJ.XueH.ChenD.LouX.XiaF.WangS. (2022). Aggregation-induced emission luminogens for assisted cancer surgery. Coord. Chem. Rev.464, 214552. 10.1016/j.ccr.2022.214552
21
D’arcyM. S. (2019). Cell death: A review of the major forms of apoptosis, necrosis and autophagy. Cell. Biol. Int.43, 582–592. 10.1002/cbin.11137
22
DingD.LiJ.XuL.WangJ.TanD.LinW. (2022). Development of an activatable hydrogen sulfide-specific two-photon fluorescent probe for bioimaging in an air pouch inflammation model. J. Mat. Chem. B10, 4568–4574. 10.1039/d2tb00681b
23
DisbrowE.StokesK. Y.LedbetterC.PattersonJ.KelleyR.PardueS.et al (2021). Plasma hydrogen sulfide: A biomarker of alzheimer's disease and related dementias. Alzheimers Dement.17, 1391–1402. 10.1002/alz.12305
24
DoricZ.NakamuraK. (2021). Mice with disrupted mitochondria used to model Parkinson's disease. Nature599, 558–560. 10.1038/d41586-021-02955-z
25
DuH.ZhangH.FanY.ZhengY.YuanS.JiaT.-T.et al (2023). A novel fluorescent probe for the detection of formaldehyde in real food samples, animal serum samples and gaseous formaldehyde. Food Chem., 135483. 10.1016/j.foodchem.2023.135483
26
FangZ.SuZ.QinW.LiH.FangB.DuW.et al (2020). Two-photon dual-channel fluorogenic probe for in situ imaging the mitochondrial H2S/viscosity in the brain of Drosophila Parkinson’s disease model. Chin. Chem. Let.31, 2903–2908. 10.1016/j.cclet.2020.03.063
27
FontaineM.LepapeA.PiriouV.VenetF.FriggeriA. (2016). Innate danger signals in acute injury: From bench to bedside. Anaesth. Crit. Care Pa.35, 283–292. 10.1016/j.accpm.2015.10.009
28
GagliardiG.VanniniP. (2022). Episodic memory impairment mediates the loss of awareness in mild cognitive impairment. Front. Aging Neurosci.13, 802501. 10.3389/fnagi.2021.802501
29
GaoJ.GaoA.LiuW.ChenL. (2021). Golgi stress response: A regulatory mechanism of Golgi function. BioFactors47, 964–974. 10.1002/biof.1780
30
GardnerS. H.ReinhardtC. J.ChanJ. (2021). Advances in activity-based sensing probes for isoform-selective imaging of enzymatic activity. Angew. Chem. Int. Ed.60, 5000–5009. 10.1002/anie.202003687
31
GongS.ZhengZ.GuanX.FengS.FengG. (2021). Near-infrared mitochondria-targetable fluorescent probe for high-contrast bioimaging of H2S. Anal. Chem.93, 5700–5708. 10.1021/acs.analchem.0c04639
32
GotoN.HaraH.KondoM.YasudaN.KamiyaT.OkudaK.et al (2020). Hydrogen sulfide increases copper-dependent neurotoxicity via intracellular copper accumulation. Metallomics12, 868–875. 10.1039/D0MT00015A
33
GreenamyreJ. T. (2018). What's wrong with mitochondria in Parkinson's disease?Mov. Disord.33, 1515–1517. 10.1002/mds.98
34
GreenwoodH. E.WitneyT. H. (2021). Latest advances in imaging oxidative stress in cancer. J. Nucl. Med.62, 1506–1510. 10.2967/jnumed.120.256974
35
GrunewaldA.KumarK. R.SueC. M. (2019). New insights into the complex role of mitochondria in Parkinson's disease. Prog. Neurobiol.177, 73–93. 10.1016/j.pneurobio.2018.09.003
36
HanaokaK.IwakiS.YagiK.MyochinT.IkenoT.OhnoH.et al (2022). General design strategy to precisely control the emission of fluorophores via a twisted intramolecular charge transfer (TICT) process. J. Am. Chem. Soc.144, 19778–19790. 10.1021/jacs.2c06397
37
HeW.-M.ZhouZ.HanZ.LiS.ZhouZ.MaL.-F.et al (2021). Ultrafast size expansion and turn-on luminescence of atomically precise silver clusters by hydrogen sulfide. Angew. Chem. Int. Ed.60, 8505–8509. 10.1002/anie.202100006
38
HicksS. W.MachamerC. E. (2005). Golgi structure in stress sensing and apoptosis. BBA Mol. Cell. Res.1744, 406–414. 10.1016/j.bbamcr.2005.03.002
39
HirayamaT.IndenM.TsuboiH.NiwaM.UchidaY.NakaY.et al (2019). A golgi-targeting fluorescent probe for labile Fe(ii) to reveal an abnormal cellular iron distribution induced by dysfunction of VPS35. Chem. Sci.10, 1514–1521. 10.1039/C8SC04386H
40
HirschE.GraybielA. M.AgidY. A. (1988). Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature334, 345–348. 10.1038/334345a0
41
HolczerM.BeszeB.ZámbóV.CsalaM.BánhegyiG.KapuyO. (2018). Epigallocatechin-3-Gallate (EGCG) promotes autophagy-dependent survival via influencing the balance of mTOR-AMPK pathways upon endoplasmic reticulum stress. Oxid. Med. Cell. Longev.2018, 1–15. 10.1155/2018/6721530
42
HouJ.-T.WangB.ZouY.FanP.ChangX.CaoX.et al (2020a). Molecular fluorescent probes for imaging and evaluation of hypochlorite fluctuations during diagnosis and therapy of osteoarthritis in cells and in a mouse model. ACS Sens.5, 1949–1958. 10.1021/acssensors.0c00270
43
HouJ.-T.YuK.-K.SunwooK.KimW. Y.KooS.WangJ.et al (2020b). Fluorescent imaging of reactive oxygen and nitrogen species associated with pathophysiological processes. Chem6, 832–866. 10.1016/j.chempr.2019.12.005
44
HouJ.-T.KwonN.WangS.WangB.HeX.YoonJ.et al (2022). Sulfur-based fluorescent probes for HOCl: Mechanisms, design, and applications. Coord. Chem. Rev.450, 214232. 10.1016/j.ccr.2021.214232
45
HuY.ShangZ.WangJ.HongM.ZhangR.MengQ.et al (2021). A phenothiazine-based turn-on fluorescent probe for the selective detection of hydrogen sulfide in food, live cells and animals. Analyst146, 7528–7536. 10.1039/d1an01762d
46
JiaT.-T.LiY.NiuH. (2022). Recent progress in fluorescent probes for diabetes visualization and drug therapy. Chemosensors10, 280. 10.3390/chemosensors10070280
47
JiangN.LiY.ShuT.WangJ. (2019). Cytokines and inflammation in adipogenesis: An updated review. Front. Med.13, 314–329. 10.1007/s11684-018-0625-0
48
JiaoX.XiaoY.LiY.LiangM.XieX.WangX.et al (2018). Evaluating drug-induced liver injury and its remission via discrimination and imaging of HClO and H2S with a two-photon fluorescent probe. Anal. Chem.90, 7510–7516. 10.1021/acs.analchem.8b01106
49
JohansenD.YtrehusK.BaxterG. F. (2006). Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia–reperfusion injury- evidence for a role of K ATP channels. Basic Res. Cardiol.101, 53–60. 10.1007/s00395-005-0569-9
50
JunT.XiaopengY.FangfangZ.DiZ.SaijunM.YongY. (2020). Visualizing peroxynitrite fuxes and protective eeffect of endogenous hydrogen sulfide during carbonyl stress in endothelial cell. Sens. Actuators B Chem.330, 129283. 10.1016/j.snb.2020.129283
51
JuvekarV.ParkS. J.YoonJ.KimH. M. (2021). Recent progress in the two-photon fluorescent probes for metal ions. Coord. Chem. Rev.427, 213574. 10.1016/j.ccr.2020.213574
52
KamounP.BelardinelliM.-C.ChabliA.LallouchiK.Chadefaux-VekemansB. (2003). Endogenous hydrogen sulfide overproduction in down syndrome. Am. J. Med. Genet. A116A, 310–311. 10.1002/ajmg.a.10847
53
KasinathB. S. (2014). Hydrogen sulfide to the rescue in obstructive kidney injury. Kidney Inter.: Official J. Inter. Soc. Nephrol.85 (6), 1255–1258. 10.1038/ki.2013.529
54
KasinathB. S.FeliersD.LeeH. J. (2018). Hydrogen sulfide as a regulatory factor in kidney health and disease. Biochem. Pharmacol.149, 29–41. 10.1016/j.bcp.2017.12.005
55
KawaiK.FujitsukaM.MaruyamaA. (2021). Single-molecule study of redox reaction kinetics by observing fluorescence blinking. Acc. Chem. Res.54, 1001–1010. 10.1021/acs.accounts.0c00754
56
KimuraH.NagaiY.UmemuraK.KimuraY. (2005). Physiological roles of hydrogen sulfide: Synaptic modulation, neuroprotection, and smooth muscle relaxation. Antioxid. Redox Signal.7, 795–803. 10.1089/ars.2005.7.795
57
KimuraY.GotoY.-I.KimuraH. (2009). Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid. Redox Signal.12, 1–13. 10.1089/ars.2008.2282
58
KimuraY.KimuraH. (2004). Hydrogen sulfide protects neurons from oxidative stress. FASEB J.18, 1165–1167. 10.1096/fj.04-1815fje
59
KongF.WangX.BaiJ.LiX.YangC.LiY.et al (2021). A "Double-locked" probe for the detection of hydrogen sulfide in a viscous system. Chem. Commun.57, 6604–6607. 10.1039/d1cc01819a
60
KoningA. M.FrenayA.-R. S.LeuveninkH. G. D.Van GoorH. (2015). Hydrogen sulfide in renal physiology, disease and transplantation-the smell of renal protection. Nitric Oxide46, 37–49. 10.1016/j.niox.2015.01.005
61
KshirsagarV.ThingoreC.GursahaniM.GawaliN.JuvekarA. (2021). Hydrogen sulfide ameliorates lipopolysaccharide-induced memory impairment in mice by reducing apoptosis, oxidative, and inflammatory effects. Neurotox. Res.39, 1310–1322. 10.1007/s12640-021-00374-6
62
KshirsagarV. V.ThingoreC.JuvekarA. (2020). Hydrogen sulfide alleviates lipopolysaccharide-induced memory impairment, neurodegeneration and neuroinflammation in Swiss albino mice. Alzheimers Dement.16, e036835. 10.1002/alz.036835
63
KushkevychI.DordevićD.VítězováM. (2021). Possible synergy effect of hydrogen sulfide and acetate produced by sulfate-reducing bacteria on inflammatory bowel disease development. J. Adv. Res.27, 71–78. 10.1016/j.jare.2020.03.007
64
LauL.-H.LewJ.BorschmannK.ThijsV.EkinciE. I. (2019). Prevalence of diabetes and its effects on stroke outcomes: A meta-analysis and literature review. J. Diabetes Invest.10, 780–792. 10.1111/jdi.12932
65
LeiG.ZhuangL.GanB. (2022). Targeting ferroptosis as a vulnerability in cancer. Nat. Rev. Cancer22, 381–396. 10.1038/s41568-022-00459-0
66
LiS. J.LiY. F.LiuH. W.ZhouD. Y.JiangW. L.Ou-YangJ.et al (2018). A dual-response fluorescent probe for the detection of viscosity and H2S and its application in studying their cross-talk influence in mitochondria. Anal. Chem.90, 9418–9425. 10.1021/acs.analchem.8b02068
67
LiH.MuJ.SunJ.XuS.LiuW.XuF.et al (2020). Hydrogen sulfide releasing oridonin derivatives induce apoptosis through extrinsic and intrinsic pathways. Eur. J. Med. Chem.187, 111978. 10.1016/j.ejmech.2019.111978
68
Li HH.KimH.XuF.HanJ.YaoQ.WangJ.et al (2022). Activity-based NIR fluorescent probes based on the versatile hemicyanine scaffold: Design strategy, biomedical applications, and outlook. Chem. Soc. Rev.51, 1795–1835. 10.1039/d1cs00307k
69
LiP. P.HeX.LiY.LamJ. W. Y.KwokR. T. K.WangC. C.et al (2022). Recent advances in aggregation-induced emission luminogens in photoacoustic imaging. Eur. J. Nucl. Med. Mol. Imaging49, 2560–2583. 10.1007/s00259-022-05726-8
70
LiS. S.HuoF.YinC. (2022). NIR fluorescent probe for dual-response viscosity and hydrogen sulfide and its application in Parkinson's disease model. Dyes Pigments197, 109825. 10.1016/j.dyepig.2021.109825
71
LiZ. Z.GaoJ.GuoZ.ZhaoH.LiuL.WangM.et al (2022). Monitoring the fluctuation of H2S in insulin-resistant HepG2 cells and diabetic mice with a dual-locked NIR fluorescent probe. Sens. Actuators B Chem.353, 131141. 10.1016/j.snb.2021.131141
72
LiY.WangY.LeiX.GuoK.AiQ.ZhangF.et al (2023). Development of a responsive probe for colorimetric and fluorescent detection of bisulfite in food and animal serum samples in 100% aqueous solution. Food Chem.407, 135146. 10.1016/j.foodchem.2022.135146
73
LiangT.QiangT.RenL.ChengF.WangB.LiM.et al (2022). Near-infrared fluorescent probe for hydrogen sulfide: High-fidelity ferroptosis evaluation in vivo during stroke. Chem. Sci.13, 2992–3001. 10.1039/d1sc05930k
74
LiberaleL.BadimonL.MontecuccoF.LüscherT. F.LibbyP.CamiciG. G. (2022). Inflammation, aging, and cardiovascular disease. J. Am. Coll. Cardiol.79, 837–847. 10.1016/j.jacc.2021.12.017
75
LimG. B. (2018). Perivascular inflammation in coronary spasm. Nat. Rev. Cardiol.15, 134–135. 10.1038/nrcardio.2018.9
76
LimH. J.Johnny OngC.-A.TanJ. W.-S.Ching TeoM. C. (2019). Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: A systematic review. Crit. Rev. Oncol. Hemat.143, 1–13. 10.1016/j.critrevonc.2019.07.002
77
LinY.SahooB. R.OzawaD.KinoshitaM.KangJ.LimM. H.et al (2019). Diverse structural conversion and aggregation pathways of alzheimer's amyloid-beta (1-40). ACS Nano13, 8766–8783. 10.1021/acsnano.9b01578
78
LiuB.TangB. Z. (2020). Aggregation-induced emission: More is different. Angew. Chem. Int. Ed.59, 9788–9789. 10.1002/anie.202005345
79
LiuY.TengL.XuC.LiuH. W.XuS.GuoH.et al (2019). A "Double-Locked" and enzyme-activated molecular probe for accurate bioimaging and hepatopathy differentiation. Chem. Sci.10, 10931–10936. 10.1039/c9sc03628h
80
LiuJ.WangX.ChengY.YuY.ZhaoM.HuangJ.et al (2022). Application of a fluorescent H2S probe based on excited-state intramolecular proton transfer for detecting latent mechanism of H2S-induced MCF-7 apoptosis. Future Med. Chem.14, 647–663. 10.4155/fmc-2021-0309
81
LobbI.SonkeE.AboalsamhG.SenerA. (2015). Hydrogen sulphide and the kidney: Important roles in renal physiology and pathogenesis and treatment of kidney injury and disease. Nitric Oxide46, 55–65. 10.1016/j.niox.2014.10.004
82
LykhmusO.MishraN.KovalL.KalashnykO.GergalovaG.UspenskaK.et al (2016). Molecular mechanisms regulating LPS-induced inflammation in the brain. Front. Mol. Neurosci.9, 19. 10.3389/fnmol.2016.00019
83
MaS.QiangJ.LiL.MoY.SheM.YangZ.et al (2019). An efficient biosensor for monitoring alzheimer's disease risk factors: Modulation and disaggregation of the Aβ aggregation process. J. Mat. Chem. B7, 4124–4132. 10.1039/C9TB00291J
84
MackM. (2018). Inflammation and fibrosis. Matrix Biol.68-69, 106–121. 10.1016/j.matbio.2017.11.010
85
MajdM.SaundersE. F. H.EngelandC. G. (2020). Inflammation and the dimensions of depression: A review. Front. Neuroendocr.56, 100800. 10.1016/j.yfrne.2019.100800
86
MannaP.GungorN.McvieR.JainS. K. (2014). Decreased cystathionine-γ-lyase (CSE) activity in livers of type 1 diabetic rats and peripheral blood mononuclear cells (PBMC) of type 1 diabetic patients. J. Biol. Chem.289, 11767–11778. 10.1074/jbc.m113.524645
87
MantovaniA.AllavenaP.SicaA.BalkwillF. (2008). Cancer-related inflammation. Nature454, 436–444. 10.1038/nature07205
88
MendesJ. A.RibeiroM. C.Reis FilhoG. J. M. V.RochaT.MuscaráM. N.CostaS. K. P.et al (2019). Hydrogen sulfide inhibits apoptosis and protects the bronchial epithelium in an allergic inflammation mice model. Int. Immunopharmacol.73, 435–441. 10.1016/j.intimp.2019.05.041
89
MilluzzoA.MaugeriA.BarchittaM.SciaccaL.AgodiA. (2021). Epigenetic mechanisms in type 2 diabetes retinopathy: A systematic review. Int. J. Mol. Sci.22, 10502. 10.3390/ijms221910502
90
MoralesI.Guzman-MartinezL.Cerda-TroncosoC.FariasG. A.MaccioniR. B. (2014). Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches. Front. Cell. Neurosci.8, 112. 10.3389/fncel.2014.00112
91
NgowiE. E.AfzalA.SarfrazM.KhattakS.ZamanS. U.KhanN. H.et al (2021). Role of hydrogen sulfide donors in cancer development and progression. Int. J. Biol. Sci.17, 73–88. 10.7150/ijbs.47850
92
O’neillS. M.KabirZ.McnamaraG.BuckleyC. M. (2017). Comorbid depression and risk of lower extremity amputation in people with diabetes: Systematic review and meta-analysis. BMJ Open Diab. Res. CA5, e000366. 10.1136/bmjdrc-2016-000366
93
OppenheimR. W.FlavellR. A.VinsantS.PrevetteD.KuanC.-Y.RakicP. (2001). Programmed cell death of developing mammalian neurons after genetic deletion of caspases. J. Neurosci.21, 4752–4760. 10.1523/JNEUROSCI.21-13-04752.2001
94
OuP.WangY.HaoC.PengY.ZhouL. Y. (2021). Naphthalimide-based a highly selective two-photon fluorescent probe for imaging of hydrogen sulfide in living cells and inflamed tissue of mouse model. Spectrochim. Acta. A Mol. Biomol. Spectrosc.245, 118886. 10.1016/j.saa.2020.118886
95
PagliassottiM. J.KimP. Y.EstradaA. L.StewartC. M.GentileC. L. (2016). Endoplasmic reticulum stress in obesity and obesity-related disorders: An expanded view. Metabolism65, 1238–1246. 10.1016/j.metabol.2016.05.002
96
PalV. K.BandyopadhyayP.SinghA. (2018). Hydrogen sulfide in physiology and pathogenesis of bacteria and viruses. IUBMB Life70, 393–410. 10.1002/iub.1740
97
PapapetropoulosA. (2016). Regulation of angiogenesis by hydrogen sulfide. Free Radic. Bio. Med.96, S4. 10.1016/j.freeradbiomed.2016.04.035
98
ParkS. Y.YoonS. A.ChaY.LeeM. H. (2021). Recent advances in fluorescent probes for cellular antioxidants: Detection of NADH, hNQO1, H2S, and other redox biomolecules. Coord. Chem. Rev.428, 213613. 10.1016/j.ccr.2020.213613
99
PaulB. D.SbodioJ. I.XuR.VandiverM. S.ChaJ. Y.SnowmanA. M.et al (2014). Cystathionine γ-lyase deficiency mediates neurodegeneration in huntington’s disease. Nature509, 96–100. 10.1038/nature13136
100
PoelmaC. (2016). Ultrasound imaging velocimetry: A review. Exp. Fluids58, 3. 10.1007/s00348-016-2283-9
101
PredmoreB. L.LeferD. J.GojonG. (2012). Hydrogen sulfide in biochemistry and medicine. Antioxid. Redox Sign17, 119–140. 10.1089/ars.2012.4612
102
QiY.-L.WangH.-R.ChenL.-L.DuanY.-T.YangS.-Y.ZhuH.-L. (2022). Recent advances in small-molecule fluorescent probes for studying ferroptosis. Chem. Soc. Rev.51, 7752–7778. 10.1039/D1CS01167G
103
QiuY.CaoY.CaoW.JiaY.LuN. (2020). The application of ferroptosis in diseases. Pharmacol. Res.159, 104919. 10.1016/j.phrs.2020.104919
104
RajasekarM. (2021). Recent trends in rhodamine derivatives as fluorescent probes for biomaterial applications. J. Mol. Struct.1235, 130232. 10.1016/j.molstruc.2021.130232
105
RamyaA. N.JosephM. M.KarunakaranV.AhammedC. V. S.SamantaA.MaitiK. K. (2022). An efficient molecular luminophore based on tetraphenylethylene (TPE) enabling intracellular detection and therapeutic benefits of hydrogen sulfide in alzheimer’s disease. Sens. Actuators B Chem.355, 131118. 10.1016/j.snb.2021.131118
106
ReddyP. H. (2009). Role of mitochondria in neurodegenerative diseases: Mitochondria as a therapeutic target in alzheimer's disease. CNS Spectr.14, 8–13. 10.1017/S1092852900024901
107
RenM.XuQ.BaiY.WangS.KongF. (2021). Construction of a dual-response fluorescent probe for copper (II) ions and hydrogen sulfide (H2S) detection in cells and its application in exploring the increased copper-dependent cytotoxicity in present of H2S. Spectrochim. Acta. A Mol. Biomol. Spectrosc.249, 119299. 10.1016/j.saa.2020.119299
108
RenT. B.WangZ. Y.XiangZ.LuP.LaiH. H.YuanL.et al (2021). A general strategy for development of activatable NIR-II fluorescent probes for in vivo high-contrast bioimaging. Angew. Chem. Int. Ed.60, 800–805. 10.1002/anie.202009986
109
ScammahornJ. J.NguyenI. T. N.BosE. M.Van GoorH.JolesJ. A. (2021). Fighting oxidative stress with sulfur: Hydrogen sulfide in the renal and cardiovascular systems. Antioxidants10, 373. 10.3390/antiox10030373
110
SedgwickA. C.DouW. T.JiaoJ. B.WuL.WilliamsG. T.JenkinsA.et al (2018). An ESIPT probe for the ratiometric imaging of peroxynitrite facilitated by binding to aβ-aggregates. J. Am. Chem. Soc.140, 14267–14271. 10.1021/jacs.8b08457
111
Sempere-BigorraM.Julian-RochinaI.CauliO. (2021). Differences and similarities in neuropathy in type 1 and 2 diabetes: A systematic review. J. Pers. Med.11, 230. 10.3390/jpm11030230
112
ShenW.WangP.XieZ.ZhouH.HuY.FuM.et al (2021). A bifunctional probe reveals increased viscosity and hydrogen sulfide in zebra fish model of Parkinson's disease. Talanta234, 122621. 10.1016/j.talanta.2021.122621
113
ShuW.ZangS.WangC.GaoM.JingJ.ZhangX. (2020). An endoplasmic reticulum-targeted ratiometric fluorescent probe for the sensing of hydrogen sulfide in living cells and zebrafish. Anal. Chem.92, 9982–9988. 10.1021/acs.analchem.0c01623
114
SicaA.WangJ. M.ColottaF.DejanaE.MatsushimaK.OppenheimJ. J.et al (1990). Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J. Immunol.144, 3034–3038. 10.4049/jimmunol.144.8.3034
115
SiesH. (1997). Oxidative stress: Oxidants and antioxidants. Exp. Physiol.82, 291–295. 10.1113/expphysiol.1997.sp004024
116
SinghN.SharmaS.SinghR.RajputS.ChattopadhyayN.TewariD.et al (2021). A naphthalimide-based peptide conjugate for concurrent imaging and apoptosis induction in cancer cells by utilizing endogenous hydrogen sulfide. Chem. Sci.12, 16085–16091. 10.1039/d1sc04030h
117
StarlingS. (2018). Alzheimer disease: Blood-derived Abeta induces AD pathology. Nat. Rev. Neurol.14, 2. 10.1038/nrneurol.2017.164
118
SuW.HuangL.ZhuL.LinW. (2022). A novel fluorescent probe for imagining hydrogen sulfide upregulation in acute lung injury. Sens. Actuators B Chem.369, 132297. 10.1016/j.snb.2022.132297
119
SunH.-J.WuZ.-Y.NieX.-W.WangX.-Y.BianJ.-S. (2021). An updated insight into molecular mechanism of hydrogen sulfide in cardiomyopathy and myocardial ischemia/reperfusion injury under diabetes. Front. Pharmacol.12, 651884. 10.3389/fphar.2021.651884
120
SunY.SunP.LiZ.QuL.GuoW. (2022). Natural flavylium-inspired far-red to NIR-II dyes and their applications as fluorescent probes for biomedical sensing. Chem. Soc. Rev.51, 7170–7205. 10.1039/D2CS00179A
121
SwerdlowR. H. (2018). Mitochondria and mitochondrial cascades in alzheimer’s disease. J. Alzheimer's Dis.62, 1403–1416. 10.3233/JAD-170585
122
SzaboC.ColettaC.ChaoC.MódisK.SzczesnyB.PapapetropoulosA.et al (2013). Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer. Proc. Natl. Acad. Sci. U.S.A.110, 12474–12479. 10.1073/pnas.1306241110
123
TabassumR.JeongN. Y.JungJ. (2020). Therapeutic importance of hydrogen sulfide in age-associated neurodegenerative diseases. Neural Regen. Res.15, 653–662. 10.4103/1673-5374.266911
124
TanG.PanS.LiJ.DongX.KangK.ZhaoM.et al (2011). Hydrogen sulfide attenuates carbon tetrachloride-induced hepatotoxicity, liver cirrhosis and portal hypertension in rats. PLoS One6, e25943. 10.1371/journal.pone.0025943
125
TangJ.YangX.ZhaoF.ZhangD.MoS.YeY. (2021). Visualizing peroxynitrite fluxes and protective effect of endogenous hydrogen sulfide during carbonyl stress in endothelial cell. Sensors and Actuators B: Chemical330, 129283. 10.1016/j.snb.2020.129283
126
VandiniE.OttaniA.ZaffeD.CalevroA.CanaliniF.CavalliniG. M.et al (2019). Mechanisms of hydrogen sulfide against the progression of severe alzheimer’s disease in transgenic mice at different ages. Pharmacology103, 50–60. 10.1159/000494113
127
WallaceJ. L. (2007). Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol. Sci.28, 501–505. 10.1016/j.tips.2007.09.003
128
WangJ.ChenG.-J. (2016). Mitochondria as a therapeutic target in alzheimer's disease. Genes Dis.3, 220–227. 10.1016/j.gendis.2016.05.001
129
WangX.-Y.YangC.-T.ZhengD.-D.MoL.-Q.LanA.-P.YangZ.-L.et al (2012). Hydrogen sulfide protects H9c2 cells against doxorubicin-induced cardiotoxicity through inhibition of endoplasmic reticulum stress. Mol. Cell. Biochem.363, 419–426. 10.1007/s11010-011-1194-6
130
WangR.LaiX.QiuG.LiuJ. (2019). Recent advances in reaction-based excited state intramolecular proton transfer (ESIPT) fluorescence probe. Chin. J. Org. Chem.39, 952–960. 10.6023/cjoc201811006
131
WangH.LiX.ZhuZ.WangH.WeiB.BaiX. (2020). Hydrogen sulfide promotes lipopolysaccharide-induced apoptosis of osteoblasts by inhibiting the AKT/NF-κB signaling pathway. Biochem. Biophys. Res. Commun.524, 832–838. 10.1016/j.bbrc.2020.02.005
132
WangK.YangX.GuoM.-Y.ChenX.-Y.LiT.YanR.et al (2022). Imaging the dynamic processes of hydrogen sulfide using a rapid “turn-on” mitochondria-targeting fluorescent probe. Sens. Actuators B Chem.369, 132285. 10.1016/j.snb.2022.132285
133
WangW. X.WangZ. Q.TanZ. K.MaoG. J.ChenD. H.LiC. Y. (2022). A nitrobenzoxadiazole-based near-infrared fluorescent probe for the specific imaging of H2S in inflammatory and tumor mice. Analyst147, 2712–2717. 10.1039/d2an00623e
134
WangY.LiS.ZhuX.ShiX.LiuX.ZhangH. (2022). A novel H2O2 activated NIR fluorescent probe for accurately visualizing H2S fluctuation during oxidative stress. Anal. Chim. Acta1202, 339670. 10.1016/j.aca.2022.339670
135
WeiW.WangC.LiD.YangZ. (2017). The content of hydrogen sulfide in plasma of cirrhosis rats combined with portal hypertension and the correlation with indexes of liver function and liver fibrosis. Exp. Ther. Med.14, 5022–5026. 10.3892/etm.2017.5133
136
WeissG.GanzT.GoodnoughL. T. (2019). Anemia of inflammation. Blood133, 40–50. 10.1182/blood-2018-06-856500
137
WhitemanM.GoodingK. M.WhatmoreJ. L.BallC. I.MawsonD.SkinnerK.et al (2010). Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide. Diabetol53, 1722–1726. 10.1007/s00125-010-1761-5
138
WlodkowicD.SkommerJ.McguinnessD.HillierC.DarzynkiewiczZ. (2009). ER-golgi network-A future target for anti-cancer therapy. Leuk. Res.33, 1440–1447. 10.1016/j.leukres.2009.05.025
139
WoodH. (2017). Alzheimer disease:peripheral Aβ clearance - a therapeutic strategy for AD?Nat. Rev. Neurol.13, 386. 10.1038/nrneurol.2017.80
140
WuD.GuY.ZhuD. (2021). Cardioprotective effects of hydrogen sulfide in attenuating myocardial ischemia-reperfusion injury (review). Mol. Med. Rep.24, 875. 10.3892/mmr.2021.12515
141
WuW.LiuB. (2021). Aggregation-induced emission: Challenges and opportunities. Natl. Sci. Rev.8, nwaa222. 10.1093/nsr/nwaa222
142
XiangA. H.WangX.MartinezM. P.GetahunD.PageK. A.BuchananT. A.et al (2018). Maternal gestational diabetes mellitus, type 1 diabetes, and type 2 diabetes during pregnancy and risk of ADHD in offspring. Diabetes Care41, 2502–2508. 10.2337/dc18-0733
143
XingP.GaoK.WangB.GaoJ.YanH.WenJ.et al (2016). HEPES is not suitable for fluorescence detection of HClO: A novel probe for HClO in absolute PBS. Chem. Commun.52, 5064–5066. 10.1039/c6cc00880a
144
XuL.ZhangJ.YinL.LongX.ZhangW.ZhangQ. (2020). Recent progress in efficient organic two-photon dyes for fluorescence imaging and photodynamic therapy. J. Mat. Chem. C8, 6342–6349. 10.1039/D0TC00563K
145
YangL.ZhangY.RenX.WangB.YangZ.SongX.et al (2020). Fluorescent detection of dynamic H2O2/H2S redox event in living cells and organisms. Anal. Chem.92, 4387–4394. 10.1021/acs.analchem.9b05270
146
YinW.-L.YinW.-G.HuangB.-S.WuL.-X. (2017). Neuroprotective effects of lentivirus-mediated cystathionine-beta-synthase overexpression against 6-OHDA-induced Parkinson's disease rats. Neurosci. Lett.657, 45–52. 10.1016/j.neulet.2017.07.019
147
YingR.WangX.-Q.YangY.GuZ.-J.MaiJ.-T.QiuQ.et al (2016). Hydrogen sulfide suppresses endoplasmic reticulum stress-induced endothelial-to-mesenchymal transition through src pathway. Life Sci.144, 208–217. 10.1016/j.lfs.2015.11.025
148
YuS.JiaJ.ZhengJ.ZhouY.JiaD.WangJ. (2021). Recent progress of ferroptosis in lung diseases. Front. Cell. Dev. Biol.9, 789517. 10.3389/fcell.2021.789517
149
ZhangM.ShanH.WangT.LiuW.WangY.WangL.et al (2013). Dynamic change of hydrogen sulfide after traumatic brain injury and its effect in mice. Neurochem. Res.38, 714–725. 10.1007/s11064-013-0969-4
150
ZhangC.ZhangQ. Z.ZhangK.LiL. Y.PluthM. D.YiL.et al (2019). Dual-biomarker-triggered fluorescence probes for differentiating cancer cells and revealing synergistic antioxidant effects under oxidative stress. Chem. Sci.10, 1945–1952. 10.1039/c8sc03781g
151
ZhangY.MastersL.WangY.WuL.PeiY.GuoB.et al (2021). Cystathionine gamma-lyase/H2S signaling facilitates myogenesis under aging and injury condition. FASEB J.35, e21511. 10.1096/fj.202002675r
152
ZhaoW. K.ZhouY.XuT. T.WuQ. (2021). Ferroptosis: Opportunities and challenges in myocardial ischemia-reperfusion injury. Oxidative Med. Cell. Longev.2021, 1–12. 10.1155/2021/9929687
153
ZhaoL.ZhouX.XieF.ZhangL.YanH.HuangJ.et al (2022). Ferroptosis in cancer and cancer immunotherapy. Cancer Commun.42, 88–116. 10.1002/cac2.12250
154
ZhaoY.ShiW.LiX.MaH. (2022). Recent advances in fluorescent probes for lipid droplets. Chem. Commun.58, 1495–1509. 10.1039/D1CC05717K
155
ZhuH.LiangC.CaiX.ZhangH.LiuC.JiaP.et al (2020a). Rational design of a targetable fluorescent probe for visualizing H2S production under Golgi stress response elicited by monensin. Anal. Chem.92, 1883–1889. 10.1021/acs.analchem.9b04009
156
ZhuH.LiuC.LiangC.TianB.ZhangH.ZhangX.et al (2020b). A new phenylsulfonamide-based golgi-targeting fluorescent probe for H2S and its bioimaging applications in living cells and zebrafish. Chem. Commun.56, 4086–4089. 10.1039/d0cc00282h
157
ZimmermannK. K.SpassovS. G.StrosingK. M.IhleP. M.EngelstaedterH.HoetzelA.et al (2018). Hydrogen sulfide exerts anti-oxidative and anti-inflammatory effects in acute lung injury. Inflammation41, 249–259. 10.1007/s10753-017-0684-4
Summary
Keywords
fluorescence probe, hydrogen sulfide, pathophysiological processes, biomarker, visualization
Citation
Jia T-T, Zhang Y, Hou J-T, Niu H and Wang S (2023) H2S-based fluorescent imaging for pathophysiological processes. Front. Chem. 11:1126309. doi: 10.3389/fchem.2023.1126309
Received
17 December 2022
Accepted
16 January 2023
Published
27 January 2023
Volume
11 - 2023
Edited by
Haidong Li, Dalian University of Technology, China
Reviewed by
Fabiao Yu, Hainan Medical University, China
Jin Zhou, Weifang Medical University, China
Xin Li, Zhejiang University, China
Updates
Copyright
© 2023 Jia, Zhang, Hou, Niu and Wang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Huawei Niu, niuhw0816@126.com; Shan Wang, smallcoral@live.cn
This article was submitted to Chemical Biology, a section of the journal Frontiers in Chemistry
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.